Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA-2: Intensified Antiplatelet Therapy in Post-PCI Patients with HOPR
NCT01955200Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, cilostazol, clopidogrel in coronary artery disease (CAD), sponsored by Jiangsu Provincial People's Hospital. Started Oct 2013; status: completed.
02
Drugs
ticagrelorcilostazolclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01955200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955200.